Genpharmasec Limited (BOM:531592)
India
· Delayed Price · Currency is INR 2.080
+0.030 (1.46%)
At close: May 13, 2025
Genpharmasec Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2015 - 2019 |
| Net Income | -1.26 | 11.25 | -2.09 | 12.57 | 10.09 | Upgrade
|
| Depreciation & Amortization | 0.42 | 0.2 | 0.14 | 0.13 | 0.05 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | 0.09 | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | - | - | 0.06 | Upgrade
|
| Provision & Write-off of Bad Debts | 4.27 | 1.75 | - | - | - | Upgrade
|
| Other Operating Activities | 2.52 | -6.1 | -3.3 | -4.26 | -4.07 | Upgrade
|
| Change in Accounts Receivable | -33.91 | 7.39 | 10.77 | -4.92 | -69.97 | Upgrade
|
| Change in Inventory | 8.33 | 2.13 | -22.08 | -42.21 | 17.9 | Upgrade
|
| Change in Accounts Payable | 10.09 | -48.51 | -8.95 | 15.74 | 55.33 | Upgrade
|
| Change in Other Net Operating Assets | -19.92 | 1.29 | 1.98 | 1.6 | 4.54 | Upgrade
|
| Operating Cash Flow | -29.46 | -30.6 | -23.44 | -21.35 | 13.92 | Upgrade
|
| Capital Expenditures | -0.18 | -0.16 | -0.81 | -0.13 | -0.52 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | 0.02 | - | - | Upgrade
|
| Investment in Securities | -176.4 | 3.33 | 2.73 | -62.32 | -18.2 | Upgrade
|
| Other Investing Activities | 4.73 | 0.23 | 0.66 | 3.27 | 5.5 | Upgrade
|
| Investing Cash Flow | -280.63 | 3.63 | 4.18 | -14.1 | -40.14 | Upgrade
|
| Long-Term Debt Issued | 54.8 | 30.4 | - | - | - | Upgrade
|
| Long-Term Debt Repaid | -57.64 | - | - | - | - | Upgrade
|
| Net Debt Issued (Repaid) | -2.84 | 30.4 | - | - | - | Upgrade
|
| Issuance of Common Stock | 484.51 | - | - | 45 | - | Upgrade
|
| Other Financing Activities | -3.2 | 0.42 | - | - | - | Upgrade
|
| Financing Cash Flow | 478.47 | 30.82 | - | 45 | - | Upgrade
|
| Net Cash Flow | 168.38 | 3.85 | -19.26 | 9.55 | -26.22 | Upgrade
|
| Free Cash Flow | -29.64 | -30.76 | -24.25 | -21.47 | 13.4 | Upgrade
|
| Free Cash Flow Margin | -9.75% | -12.05% | -8.88% | -10.08% | 8.12% | Upgrade
|
| Free Cash Flow Per Share | -0.10 | -0.11 | -0.09 | -0.08 | 0.03 | Upgrade
|
| Cash Income Tax Paid | 0.41 | -2.55 | 0.3 | 3.51 | 0.53 | Upgrade
|
| Levered Free Cash Flow | -29.15 | -43.65 | -44.21 | 7.35 | -39.63 | Upgrade
|
| Unlevered Free Cash Flow | -26.59 | -43.3 | -44.21 | 7.35 | -39.63 | Upgrade
|
| Change in Net Working Capital | 26.85 | 44.89 | 40.2 | 0.03 | 43.21 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.